logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 16
  • 1
    Bradman, Godfrey Michael
    Director born in September 1936
    Individual (76 offsprings)
    Officer
    2016-08-25 ~ 2018-01-04
    OF - Director → CIF 0
  • 2
    Tufaro, Frank
    Born in December 1954
    Individual (1 offspring)
    Officer
    2022-08-17 ~ now
    OF - Director → CIF 0
  • 3
    Pagani, Sergio
    Born in May 1971
    Individual (3 offsprings)
    Officer
    2018-08-01 ~ 2025-11-14
    OF - Director → CIF 0
  • 4
    Dong, Yixiang
    Accountant And Scientist born in January 1982
    Individual (1 offspring)
    Officer
    2017-08-10 ~ 2022-08-17
    OF - Director → CIF 0
  • 5
    Chia, Dr Poh Hui
    Born in March 1983
    Individual (1 offspring)
    Officer
    2024-01-05 ~ now
    OF - Director → CIF 0
  • 6
    Lim, Xinhong, Dr
    Director born in May 1982
    Individual (1 offspring)
    Officer
    2020-09-24 ~ 2024-01-05
    OF - Director → CIF 0
  • 7
    King, David Anthony, Sir
    Director born in August 1939
    Individual (11 offsprings)
    Officer
    2018-03-15 ~ 2019-11-22
    OF - Director → CIF 0
  • 8
    Rake, Michael Derek Vaughn, Sir
    Company Director born in January 1948
    Individual (1 offspring)
    Officer
    2022-12-08 ~ 2024-09-03
    OF - Director → CIF 0
  • 9
    Oakes, Herbert
    Director born in June 1946
    Individual (14 offsprings)
    Officer
    2016-08-25 ~ 2018-04-23
    OF - Director → CIF 0
  • 10
    Rademacher, Thomas William, Professor
    Born in May 1950
    Individual (7 offsprings)
    Officer
    2016-01-18 ~ now
    OF - Director → CIF 0
    Professor Thomas William Rademacher
    Born in May 1950
    Individual (7 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Has significant influence or control → CIF 0
  • 11
    Philip, Mohan, Dr
    Company Director born in October 1952
    Individual (1 offspring)
    Officer
    2017-04-01 ~ 2021-01-04
    OF - Director → CIF 0
  • 12
    Moore-thornicroft, Storme Jo-anne
    Born in March 1974
    Individual (11 offsprings)
    Officer
    2016-01-18 ~ now
    OF - Director → CIF 0
  • 13
    Jackson, David Clifford
    Born in December 1948
    Individual (8 offsprings)
    Officer
    2022-08-17 ~ now
    OF - Director → CIF 0
    Jackson, David Clifford
    Director born in December 1948
    Individual (8 offsprings)
    2016-08-25 ~ 2019-12-08
    OF - Director → CIF 0
  • 14
    De Godoi Mattos Ferreira, Ricardo, Dr
    Born in January 1980
    Individual (1 offspring)
    Officer
    2023-09-27 ~ now
    OF - Director → CIF 0
  • 15
    Sedgwick, Anthony David, Professor
    Director born in March 1955
    Individual (8 offsprings)
    Officer
    2021-04-16 ~ 2022-08-17
    OF - Director → CIF 0
  • 16
    Seng Chin, Finian Tan, Dr
    Born in March 1962
    Individual (2 offsprings)
    Officer
    2019-09-03 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

GYLDEN PHARMA LIMITED

Previous name
EMERGEX VACCINES HOLDING LIMITED - 2024-10-16
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
1,290,781 GBP2024-03-31
1,393,380 GBP2023-03-31
Property, Plant & Equipment
3,168,233 GBP2024-03-31
4,232,284 GBP2023-03-31
Fixed Assets
4,459,014 GBP2024-03-31
5,625,664 GBP2023-03-31
Debtors
2,279,820 GBP2024-03-31
2,852,839 GBP2023-03-31
Cash at bank and in hand
517,012 GBP2024-03-31
2,432,587 GBP2023-03-31
Current Assets
2,796,832 GBP2024-03-31
5,285,426 GBP2023-03-31
Creditors
Amounts falling due within one year
-5,211,622 GBP2024-03-31
-3,499,615 GBP2023-03-31
Net Current Assets/Liabilities
-2,414,790 GBP2024-03-31
1,785,811 GBP2023-03-31
Total Assets Less Current Liabilities
2,044,224 GBP2024-03-31
7,411,475 GBP2023-03-31
Creditors
Amounts falling due after one year
-311,004 GBP2023-03-31
Net Assets/Liabilities
1,799,977 GBP2024-03-31
6,856,224 GBP2023-03-31
Equity
Called up share capital
41 GBP2024-03-31
39 GBP2023-03-31
Share premium
47,127,444 GBP2024-03-31
38,793,395 GBP2023-03-31
Retained earnings (accumulated losses)
-55,624,213 GBP2024-03-31
-39,263,735 GBP2023-03-31
Equity
1,799,977 GBP2024-03-31
6,856,224 GBP2023-03-31
Average Number of Employees
392023-04-01 ~ 2024-03-31
352022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
1,750,886 GBP2024-03-31
1,748,831 GBP2023-03-31
Intangible assets - Disposals
-256,022 GBP2023-04-01 ~ 2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
460,105 GBP2024-03-31
355,451 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
169,846 GBP2023-04-01 ~ 2024-03-31
Intangible assets - Disposals and decrease in the amortization or impairment
-62,010 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
6,383,449 GBP2024-03-31
6,383,079 GBP2023-03-31
Property, Plant & Equipment - Disposals
-94,339 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Total increase or decrease resulting from revaluations
-59,343 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
3,215,216 GBP2024-03-31
2,150,795 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,165,482 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-70,110 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Other increase or decrease in the depreciation or impairment
-30,951 GBP2023-04-01 ~ 2024-03-31
Related profiles found in government register
  • GYLDEN PHARMA LIMITED
    Info
    EMERGEX VACCINES HOLDING LIMITED - 2024-10-16
    Registered number 09955881
    4 & 5 Dunmore Court Wootton Road, Abingdon, Oxfordshire OX13 6BH
    PRIVATE LIMITED COMPANY incorporated on 2016-01-18 (10 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-08-07
    CIF 0
  • EMERGEX VACCINES HOLDING LIMITED
    S
    Registered number 09955881
    4&5, Dunmore Court, Wootton Road, Abingdon, Oxfordshire, United Kingdom, OX13 6BH
    Corporate in Companies House, England And Wales
    CIF 1
    Private Limited Company in Companies House, England And Wales
    CIF 2 CIF 3
child relation
Offspring entities and appointments 3
  • 1
    BARSOOM LIMITED
    14817691
    4&5 Dunmore Court, Wootton Road, Abingdon, Oxfordshire, United Kingdom
    Dissolved Corporate (2 parents)
    Person with significant control
    2023-04-20 ~ dissolved
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Ownership of shares – 75% or more → OE
  • 2
    EMERGEX VACCINES LIMITED
    12434233
    4&5 Dunmore Court, Wootton Road, Abingdon, Oxfordshire, United Kingdom
    Dissolved Corporate (3 parents)
    Equity (Company account)
    1 GBP2023-03-31
    Person with significant control
    2020-01-30 ~ dissolved
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
  • 3
    GYLDEN LIMITED
    14818028
    4&5 Dunmore Court, Wootton Road, Abingdon, Oxfordshire, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    1 GBP2024-03-31
    Person with significant control
    2023-04-20 ~ now
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.